Achillion Pharmaceuticals, Inc. (ACHN) stock coverage started with “Buy” in note to investors by Ladenburg Thalmann Financial Services

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares rose on Thursday February 2 on lighter trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, The Dow Jones Industrial Average DJIA, -0.10% fell 34 points, or 0.2%, to 19,858. The S&P 500 SPX, -0.11% lost 4 points to 2,276, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.05% slid 16 points, or 0.3%, to 5,626. Among the most actively traded Nasdaq stocks was Facebook Inc FB, +0.31% which fell 0.7% a day after it reported its quarterly results.

Analysts at Ladenburg Thalmann Financial Services initiated coverage on Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) stock, starting the company at Buy. With a rating of Buy on the stock, the company has a 52-week high of $10.06. The one-year price target of $8.95 is higher than the opening price of $4.25, that has caused a number of other analysts to comment on the company recently. Analysts and brokerage firms will subsequently re periodic updates after initiating coverage,. Changes in price targets are not unheard of.

Yesterday Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares last traded at $4.31, a jump of $0.20 over the previous closing price. Opening at $4.25, they varied from $4.16 and $4.32 throughout the day.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) now has a market cap of 588.41M.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Average Daily Trading Volume

440,975 shares traded hands yesterday, 20 percent lower than the norm, out of a total float 93,018,000. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these have substantial teams of analysts researching thousands of stocks, so it is good corroboration to see them taking a postion in a stock you are researching.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.

With that in mind, Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) now has a 50-day MA of $4.17 and 200-day MA of $6.38. It has traded in a 52-week range between $3.78 – 10.060 and today’s last price is 57.21%% lower than the 52 week high of $10.06.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors look for companies that have increased their earnings at least 25% or more over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *